TLR3 Plays Significant Roles against HBV-Associated HCC

Area of Science:

• Immunology
• Hepatology
• Oncology

Background:

• Toll-like receptor 3 (TLR3) recognizes viral double-stranded RNA (dsRNA) and is crucial for immune responses.
• The role of TLR3 in hepatocellular carcinoma (HCC) associated with hepatitis B virus (HBV) infection remains unclear.
• Understanding TLR3's function in HBV-related HCC is vital for developing targeted therapies.

Purpose of the Study:

• To investigate the expression and function of TLR3 in human HCC tissues with HBV infection.
• To determine the correlation between TLR3 expression and clinicopathological features, immune cell infiltration, and tumor cell apoptosis in HCC.
• To evaluate the effect of TLR3 activation on HBV replication and apoptosis in HCC cell lines.

Main Methods:

• Tissue microarray analysis of 80 HCC cases using immunohistochemistry for TLR3, hepatitis B surface antigen (HBsAg), and interstitial cells.
• TUNEL staining to assess tumor cell apoptosis.
• In vitro experiments using HepG2.2.15 cells treated with TLR3 agonist dsRNA to measure HBV secretion and apoptosis.

Main Results:

• Cytoplasmic TLR3 expression in HCC tissues was positively associated with HBsAg infection and cirrhosis.
• Increased TLR3 expression correlated with enhanced interstitial immunoreactive cell infiltration and tumor cell apoptosis.
• In HepG2.2.15 cells, dsRNA treatment inhibited HBV secretion and induced apoptosis.

Conclusions:

• TLR3 signaling is implicated in the immune response against HBV in HCC.
• TLR3 expression in HCC is linked to HBV infection status and influences the tumor microenvironment.
• Targeting TLR3 may offer a therapeutic strategy for HBV-related HCC.